🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2024-04-18
Trial ID
NCT06928376
Study CSL324\_1002 will investigate the safety and pharmacokinetics of repe...
Status
Completed
Location
Holdsworth House Medical Practice
Start Date
2019-07-04
Trial ID
NCT03972280
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of decitabine ...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2016-11-17
Trial ID
NCT02921061
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Unknown
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Start Date
1999-10
Trial ID
NCT00004903
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Terminated
Location
University of Minnesota Cancer Center
Start Date
2000-08
Trial ID
NCT00005986
A Phase III, Multi-Center, Randomized, Open-Label, Active-Controlled Trial ...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2018-04-12
Trial ID
NCT04174599
This study will compare treatment emergent incidence rate of ADA between TP...
Status
Completed
Location
Celerion Inc.
Start Date
2017-03-25
Trial ID
NCT03202927
Treatments Being Tested
Determination of the effect of balugrastim on the duration and severity of ...
Status
Completed
Location
Multiple Locations
Start Date
2008-08-21
Trial ID
NCT00837265
Treatments Being Tested
The goal of this clinical trial is to estimate the rate (probability) of co...
Status
Recruiting
Location
First Affiliated Hospital Of University of Science and Technology of China
Start Date
2024-01-01
Trial ID
NCT06221683
This pilot phase I trial studies the side effects and best dose of human im...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2016-08-15
Trial ID
NCT02343666